![Markus Loeffler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Markus Loeffler
Directeur Technique/Scientifique/R&D chez
NH THERAGUIX SAS
Profil
Dr. Markus Loeffler is a Chief Medical Officer at Helix BioPharma Corp.
and a Chief Medical Officer at NH TherAguix SAS. He received his MBA from INSEAD and a doctorate degree from the University of Innsbruck.
Postes actifs de Markus Loeffler
| Sociétés | Poste | Début |
|---|---|---|
| NH THERAGUIX SAS | Directeur Technique/Scientifique/R&D | 01/01/2020 |
| HELIX BIOPHARMA CORP. | Directeur Technique/Scientifique/R&D | 18/08/2026 |
Formation de Markus Loeffler
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
25
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Helix BioPharma Corp.
 Helix BioPharma Corp. Pharmaceuticals: MajorHealth Technology Develops drugs for the prevention and treatment of cancer | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Innsbruck
 University of Innsbruck Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NH TherAguix SAS
 NH TherAguix SAS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops nanomedicine for cancer, combining imaging and radiotherapy | Health Technology |
